Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraovarian platelet-rich plasma plus growth hormone in poor ovarian responders undergoing IVF
IRCT20091012002576N32Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, double-blind trial of somatropin and platelet-rich plasma in female infertility and Diminished Ovarian Reserve (DOR) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Number of oocytes, Chemical pregnancy and 1 more. Started Sep 2023; status: completed.
02
Drugs
somatropinplatelet-rich plasma
03
Conditions
female infertilityDiminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on IRCT20091012002576N32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091012002576N32.